Topic: synthetic lethality

Tango Therapeutics

Tango uses CRISPR-enabled synthetic lethality to target cancer, but what really sets it apart is its paradigm-shifting approach that puts patient selection before target identification.

Repare Therapeutics

CRISPR has made it possible for Repare to increase both the scale and precision of the search for drug targets that can induce synthetic lethality in cancer cells.